|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
1P20CA192990-01
|
$177,045
|
$106,227
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
5R01CA180277-02
|
$267,356
|
$267,356
|
LI, XIN
|
NEW YORK UNIVERSITY
|
|
(PQB5) Does the timing of Pten and Rb1 mutation affect prostate cancer phenotypes
|
5R21CA179907-02
|
$179,119
|
$179,119
|
GOODRICH, DAVID
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQB6) Accurate Comparative Genome-wide Analysis of Primary Tumors and Metastases
|
5R21CA180016-02
|
$166,671
|
$83,336
|
WOTTON, DAVID
|
UNIVERSITY OF VIRGINIA
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
1R01CA185457-01
|
$1,044,796
|
$1,044,796
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
5R21CA179981-02
|
$159,287
|
$79,644
|
HENRY, MICHAEL
|
UNIVERSITY OF IOWA
|
|
(PQC3) Using an Immunoscore to Assess Tumor-medicated Immune Variations in Africa
|
1R21CA190076-01
|
$127,238
|
$127,238
|
WALLACE, TIMOTHY
|
BON SECOURS RICHMOND COMMUNITY HOSPITAL
|
|
(PQC4) Habitats in Prostate Cancer
|
1R01CA190105-01
|
$730,977
|
$730,977
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
(PQD-1) NF-kB activation and enzalutamide therapy in metastatic castration resist
|
5R21CA179970-02
|
$162,451
|
$162,451
|
GAO, ALLEN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
1R01CA185509-01
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$137,083
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192973-01
|
$191,836
|
$95,918
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
1P20CA192992-01
|
$171,144
|
$102,686
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192976-01
|
$144,556
|
$67,941
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2014 AUA Urological Oncology Research Symposium: ""Progress in Translational Uro
|
1R13CA186649-01
|
$6,000
|
$2,040
|
GIAMBARRESI, LEO
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
3rd Biennial Science of Global Prostate Cancer Disparities in Black Men
|
1R13CA189451-01
|
$45,000
|
$45,000
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
402 -- TITLE: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TR
|
261201200031I
|
$3,052,930
|
$3,052,930
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF ARIZONA
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-05
|
$339,713
|
$84,928
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$101,762
|
$50,881
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-04
|
$1,660,228
|
$464,864
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A Network Analytic Approach to Modeling Variation in Prostate Cancer Care
|
5K07CA151910-04
|
$156,570
|
$156,570
|
POLLACK, CRAIG
|
JOHNS HOPKINS UNIVERSITY
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5U01CA166894-02
|
$358,782
|
$358,782
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis
|
5R01CA151623-04
|
$326,999
|
$326,999
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
A novel strategy to identify prostate cancer biomarkers for patient management
|
5R01CA172603-02
|
$309,964
|
$309,964
|
HUANG, JIAOTI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-04
|
$283,563
|
$283,563
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
A Potent Small Molecule Chemokine Antagonist Blocks Tumor Cell Dissemination In V
|
1R43CA183362-01A1
|
$224,748
|
$112,374
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
A progressive cone-beam CT dose control scheme for image-guided radiation therapy
|
1R21CA178787-01A1
|
$172,913
|
$86,457
|
JIA, XUN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
A smart needle guide template for MRI-guided transperineal prostate biopsy
|
1R41CA192446-01
|
$167,653
|
$167,653
|
MAGILL, JOHN
|
PHYSICAL SCIENCES, INC
|
|
A Systems Biology Approach to the Development of Cancer Biomarkers
|
5U01CA111275-10
|
$614,261
|
$614,261
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN
|
|
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment
|
3R01CA164388-03S1
|
$36,766
|
$36,766
|
ZENG, GANG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment
|
5R01CA164388-03
|
$309,964
|
$309,964
|
ZENG, GANG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
$53,831
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$1,500
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$148,994
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accurate Prostate Cancer Diagnosis for Active Surveillance Patients Using a Novel
|
1R41CA183315-01
|
$161,003
|
$161,003
|
MONTGOMERY, JEFFREY
|
PRODEVICE MEDICAL SUPPLIES AND EQUIPMENT
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-05
|
$314,143
|
$219,900
|
MAHAJAN, NUPAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
ACN 12011-001-00002 NCI-EARLY DETECTION NETWORK REFERENCE LAB AT USU-CPDR
|
ACN12011001
|
$459,666
|
$459,666
|
UNKNOWN, UNKNOWN
|
UNKNOWN
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$107,428
|
$21,486
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Adaptable Polymer Micelles for Tumor Targeting
|
5R01CA129287-05
|
$289,877
|
$144,939
|
PARK, KINAM
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Addressing Prostate Cancer Information Disparities with eHealth Technology
|
5R21CA178296-02
|
$167,844
|
$167,844
|
ALLEN, JENNIFER
|
TUFTS UNIVERSITY BOSTON
|
|
Advanced PET/CT Imaging for Improving Clincail Trials
|
5U01CA148131-05
|
$539,050
|
$269,525
|
KINAHAN, PAUL
|
UNIVERSITY OF WASHINGTON
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-03
|
$421,068
|
$421,068
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention
|
1K05CA175147-01A1
|
$88,959
|
$88,959
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Akt isoform-specific signaling in breast cancer metastasis
|
4R00CA157945-03
|
$224,100
|
$56,025
|
CHIN, YUET MING REBECCA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$632,455
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$13,684
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$15,880
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$1,010
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AMH and prostate cancer risk in PLCO
|
ZIA CP010180 - 10675
|
$11,524
|
$11,524
|
Cook, Michael
|
DCEG (NCI)
|
|
Amoeboid Membrane Dynamics in Prostate Cancer
|
5R01CA143777-05
|
$384,579
|
$384,579
|
FREEMAN, MICHAEL
|
CEDARS-SINAI MEDICAL CENTER
|
Total relevant funding to Prostate for this search: $217,811,379
|